Sign in
CompletedNo phase

Can Shock Indices Be Prognostic Indicators in Sepsis/Septic Shock?

Key facts

Who runs it
Başakşehir Çam & Sakura City Hospital
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1,522 people enrolled
Started
1 Dec 2012
Ended
1 Feb 2024
Type of study
Observational
Treatments tested
  • Measurement of hemodynamic parameters.
Record updated
16 May 2024

Who can take part

Age
18 years to 80 years
Sex
Women and men

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients with a preliminary diagnosis of sepsis/septic shock in the intensive care unit
  • Adult patients aged between 18 and 80 years

Who cannot take part

  • Patients suspected of having COVID-19 pneumonia
  • Patients with confirmed COVID-19, validated by thoracic computed tomography images and nasal swab PCR results
  • Patients under 18 years old
  • Pregnant patients
  • Patients with incomplete data
  • Patients for whom outcome information is unavailable due to referral to an external center
  • Patients discharged from the intensive care unit within 24 hours

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

We evaluated the ability of shock indices and hemodynamic parameters to predict 28-day ICU mortality.

The group in the trial

  • Group Sepsis

    The group consists of 1,522 patients treated in the intensive care unit for sepsis/septic shock.

    Treatment: Measurement of hemodynamic parameters.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 May 2024